Literature DB >> 29169662

Effects of Contrast Enhancement on In-Body Calibrated Phantomless Bone Mineral Density Measurements in Computed Tomography.

Nuran Abdullayev1, Victor-Frederic Neuhaus1, Grischa Bratke1, Sebastian Voss1, Nils Große Hokamp1, Martin Hellmich2, Barbara Krug1, David Maintz1, Jan Borggrefe3.   

Abstract

We aimed to test the potential of phantomless volumetric bone mineral density (PLvBMD) measurements for the determination of volumetric bone mineral density (vBMD) in routine contrast-enhanced computed tomography (CECT). We evaluated 56 tri-phasic abdominal computed tomography scans, including an unenhanced scan as well as defined CECT scans in the arterial and portalvenous phase. PLvBMD analysis was performed by 4 radiologists using an FDA-approved tool for phantomless evaluation of bone density (IntelliSpace, Philips, The Netherlands). Mean vBMD of the first 3 lumbar vertebrae in each contrast phase was determined and interobserver variance of vBMD independent of contrast phase was analyzed using intraclass correlation, Bland-Altman plots, and Student's t test. CECT scans were associated with a significantly higher PLvBMD compared with unenhanced scans (unenhanced computed tomography: 97.8 mg/cc; arterial CECT: 106.3 mg/cc, portalvenous CECT: 106.3 mg/cc). Overall, there was no significant difference of PLvBMD between data acquisition in arterial and portalvenous phases (increase of 8.6% each, standard deviation ratio 37.7%-38.3%). In Bland-Altman analysis, there was no evidence of a relevant reader-related bias or an increase in standard deviation of PLvBMD measurements in contrast-enhanced scans compared with unenhanced scans. The following conversion formulas for unenhanced PLvBMD were determined: unenhancedPLvBMD=0.89×arterialPLvBMD+3,74mg/cc(r2 = 0.94) and unenhancedPLvBMD=0.88×venousPLvBMD+4,56mg/cc(r2 = 0.93). Compared with the results of phantom-based quantitative computed tomography measurements reported in the literature, the PLvBMD changes associated with contrast enhancement were relatively moderate with an increase of 8.6% in average. The time-point of the contrast-enhanced PLvBMD measurements after injection of contrast media did not appear to affect the results. With the adjustment formulas provided in this study, the method can improve osteoporosis screening through detection of reduced bone mass of the vertebrae in routinely conducted CECT.
Copyright © 2017 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; contrast enhancement; in-body calibration; phantomless vBMD; vertebra

Mesh:

Substances:

Year:  2017        PMID: 29169662     DOI: 10.1016/j.jocd.2017.10.001

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  2 in total

Review 1.  X-ray-based quantitative osteoporosis imaging at the spine.

Authors:  M T Löffler; N Sollmann; K Mei; A Valentinitsch; P B Noël; J S Kirschke; T Baum
Journal:  Osteoporos Int       Date:  2019-11-14       Impact factor: 4.507

2.  Phantomless assessment of volumetric bone mineral density using virtual non-contrast images from spectral detector computed tomography.

Authors:  David Zopfs; Simon Lennartz; Charlotte Zaeske; Martin Merkt; Kai Roman Laukamp; Robert Peter Reimer; David Maintz; Jan Borggrefe; Nils Grosse Hokamp
Journal:  Br J Radiol       Date:  2020-03-04       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.